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INTRODUCTION
Buckwheat is a common crops in Asia and Europe, and it
is one of the most highly potent food allergens. Sensitization
to buckwheat usually occurs by ingestion, but it can also occur
by inhalation due to occupational or domestic exposure to
flour (1-8). In 1909, Smith described a young patient who
showed severe manifestations of asthma, allergic rhinitis,
urticaria, and angioedema after ingesting of a small amount
of buckwheat, the allergic symptoms were also induced by
buckwheat inhalation (2). While there have been several relat-
ed clinical reports on buckwheat allergy during the past 30
yr, a lack of epidemiologic studies has made it difficult to
estimate the prevalence or incidence of allergic manifestations
to buckwheat among populations in different countries. 
In Korea, buckwheat flour is an important food allergen in
school children and adults. Its positive skin test rate is about
5% (9). Several case reports have been issued on buckwheat
hypersensitivity in Korea; two cases by the ingestion of cold
noodle containing buckwheat flour (10), three cases by the
inhalation of flour attached to a buckwheat husk pillow (11),
and one case of occupational asthma by the inhalation of buck-
wheat flour in noodle making factory (12). Several allergenic
components of buckwheat have been identified, and 24, 19,
16, and 9 kDa proteins are strong candidate major allergens
in Korean allergic patients (13). Moreover, the 24 kDa  -
chain of 11S globulin, has been identified a major allergen
in Japan (14).
Buckwheat is one of the main dietary corps in Korea and
Japan, furthermore, buckwheat consumption is increasing
due to its nutritional benefits. Like peanut allergy, an allergic
reaction to buckwheat is very severe and could be near fatal
(2, 4, 15), but no satisfactory epidemiologic or mechanistic
study has been reported, furthermore no effective therapy is
available for this type of allergy. Consequently, animal mod-
els of buckwheat allergy, which mimic the immunological
characteristics of buckwheat allergy in man, would be valu-
able tools for mechanistic research into grain allergies, such
as, buckwheat, wheat and rice allergies. As far as we know, no
study has been conducted on an animal model of buckwheat
allergy. For this reason, we undertook this experiment with
a view towards conducting further research.  
There are several significant obstacles to the development
of murine model of food allergy, such as, the strong innate
tendency of animals to develop immunological tolerance to
ingested antigens (Ag). Various studies in mice have shown
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Murine Model of Buckwheat Allergy by Intragastric Sensitization with
Fresh Buckwheat Flour Extract
Food allergies affect about 4% of the Korean population, and buckwheat allergy is
one of the most severe food allergies in Korea. The purpose of the present study
was to develop a murine model of IgE-mediated buckwheat hypersensitivity induced
by intragastric sensitization. Young female C3H/HeJ mice were sensitized and
challenged intragastricly with fresh buckwheat flour (1, 5, 25 mg/dose of proteins)
mixed in cholera toxin, followed by intragastric challenge. Anaphylactic reactions,
antigen-specific antibodies, splenocytes proliferation assays and cytokine produc-
tions were evaluated. Oral buckwheat challenges of sensitized mice provoked
anaphylactic reactions such as severe scratch, perioral/periorbital swellings, or
decreased activity. Reactions were associated with elevated levels of buckwheat-
specific IgE antibodies. Splenocytes from buckwheat allergic mice exhibited signif-
icantly greater proliferative responses to buckwheat than non-allergic mice. Buck-
wheat-stimulated IL-4, IL-5, and INF- productions were associated with elevated
levels of buckwheat-specific IgE in sensitized mice. In this model, 1 mg and 5 mg
dose of sensitization produced almost the same degree of Th2-directed immune
response, however, a 25 mg dose showed blunted antibody responses. In conclu-
sion, we developed IgE-mediated buckwheat allergy by intragastric sensitization
and challenge, and this model could provide a good tool for future studies.
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that oral tolerance is influenced by strain (16, 17), age at first
feeding (18-20), and the dose and nature of Ag (21, 22). In
the present study, we employed a slightly modified approach
of that used to generate a murine model of peanut-induced
anaphylaxis by Li et al. (23). We demonstrated that imme-
diate hypersensitivity reactions to buckwheat can be induced
by intragastric sensitization and challenge. To validate the
immunological relevance of this model to human buckwheat
allergy, T and B cell responses to buckwheat extract, were
evaluated by measuring serum antigen specific IgE, IgG anti-
body responses, splenocytes proliferation, and cytokine pro-
ductions.
MATERIALS AND METHODS
Mice and reagents 
Female C3H/HeJ mice, 5 weeks of age were purchased from
the Jackson Laboratory (Bar Harbor, ME, U.S.A.) and main-
tained on buckwheat free chow, under specific pathogen-free
conditions. Standard guidelines (24) for the care and use of
animals were followed. 
Fresh buckwheat flour was employed as an antigen for sen-
sitization and challenge. Crude buckwheat extract was pre-
pared as described previously (11). Cholera toxin (CT), con-
canavalin A (Con A), albumin was purchased from Sigma
(St. Louis, MO, U.S.A.). Antibodies for ELISAs (Sigma) and
ELISA kits to determine cytokine levels were purchased from
the PharMingen (San Diego, CA, U.S.A.). 
Intragastric sensitization and challenge 
Mice were sensitized by intragastric (ig) feeding with fresh
buckwheat flour solution on experimental days 0, 1, 2 and
boosted on day 7. Intragastric feeding was performed by means
of a stainless steel gavage needle, as described previously (23).
To determine the optimum sensitization dose, mice were fed
by ig with 1 mg (low dose), 5 mg (intermediate dose) or 25 mg
per mouse (high dose) of buckwheat together with 10  g/
mouse of cholera toxin. Three weeks following this initial
sensitization, mice were challenged ig with buckwheat at 10
mg/mouse divided in 2 doses at 30 min. intervals. The experi-
ments were repeated twice using the same experimental pro-
tocol, and from the three experiments were controlled.
Assessment of hypersensitivity reactions
Anaphylactic symptoms were evaluated 30 min after the
second challenge using the scoring system used in a peanut
allergy model (23): 0-no symptoms; 1-scratching and rubbing
around the nose and head; 2-puffiness around the eyes and
mouth, diarrhea, pilar erecti, reduced activity, and/or decreased
activity with an increased respiratory rate; 3-wheezing, labored
respiration, cyanosis around the mouth and tail; 4-no activi-
ty after prodding, or tremor and convulsion; 5-death.
Measurement of buckwheat-specific IgE, IgG1 and IgG2a
Tail vein blood was obtained at weekly intervals following
the initial sensitization. Sera were collected and stored at -80
℃. Levels of buckwheat-specific IgE were measured by ELISA.
Briefly, Immulon II 96-well plates (Dynatech Laboratories,
Inc., Chantilly, VA, U.S.A.) were coated with 2 g/mL crude
buckwheate extract in coating buffer, pH 9.6 (Sigma). After
an overnight incubation at 4℃, plates were washed and block-
ed with 1% BSA-PBS for 1 hr at 37℃. Following 3 washes,
serum samples (1:10 diluted) were added to the plates and
incubated overnight at 4℃. Plates were then washed 3×
and 100  L of biotinylated rat anti-mouse IgE (0.5  g/mL)
was added to each well. The plates were then incubated for
1 hr at 37℃, washed 3×, and 100 L of avidin peroxidase
(Sigma) (1:2,000 dilution) was added for an additional 30
min at room temperature. The plates were then washed 6×
and ABTS (KPL, Gaithersburg, MD, U.S.A.) was added for
30 min at room temperature. The resulting reactions were
read at 405 nm. Levels of IgE were calculated using a stan-
dard curve for measuring monoclonal antibody based on the
ELISA method for total IgE (Sigma). 
For determine PN-specific IgG1 and IgG2a levels, plates
were coated with crude buckwheat extract and then blocked
and washed in the same manner as described above. Samples
(1:500 dilution) were added to the plates and incubated over-
night at 4℃. The plates were then washed and biotinylated
rat anti-mouse IgG1 or IgG2a monoclonal antibodies (1 g/
mL) were added to the plates to detect IgG1 and IgG2a, res-
pectively. The plates were then incubated for an additional
1 hr at room temperature. After washings, avidin peroxidase
was added for an additional 15 min at room temperature, and
after an additional 8 washes, reactions were developed with
ABTS for 15-30 min at room temperature and absorbance
was read at 405 nm. 
Proliferation assays 
Spleens were removed from buckwheat sensitized and naive
mice after re-challenge with buckwheat flour at week 5. Spleen
cells were isolated and suspended in complete culture medium
(RPMI 1640 plus 10% fetal bovine serum, 1% penicillin/
streptomycin, and 1% glutamine). Spleen cells (1×106/well
in 0.2 mL) were incubated in triplicate cultures in microwell
plates in the presence or absence of crude buckwheat extract
(250 and 500  g/mL). Cells stimulated with Con A (2  g/mL)
were used as a positive control. Three days later, the cultures
were pulsed for 18-hr with 1  Ci per well of 3H-thymidine.
The cells were then harvested and the incorporated radioac-
tivity was counted in a  -scintillation counter. Results are
expressed as ratios of counts per minute (cpm) of unstimu-568 S.-Y. Lee, S. Oh, K. Lee, et al.
lated- versus stimulated-wells.
Quantification of cytokines in splenocyte culture super-
natant
Splenocytes were cultured in 24 well plates (4×106/well/
mL) in the presence or absence of PN (50  g/mL) or Con A
(2  g/mL). IFN- , IL-4, and IL-5 levels in supernatants collect-
ed after 72 hr of culture were determined by ELISA according
to the manufacturer’s instructions (PharMingen).
Statistical analysis 
Statistical analyses were performed using the Student’s t-
test for two group comparisons and using one-way ANOVA
to compare more than two groups. A p value of <0.05 was
considered statistically significant. All statistical analyses
were performed using SigmaStat software (SPSS Inc. Chica-
go, IL, U.S.A.).
RESULTS
Systemic anaphylactic reactions following intragastric
challenge
Three weeks following the initial sensitization, mice were
fed crude buckwheat extract ig at 30-40 min intervals. Sys-
temic anaphylactic symptoms were evident within 5-15 min
of the first challenge. The severity of this anaphylaxis was
evaluated 30-40 min after the first and second challenges.
The initial reactions consisted primarily of cutaneous reac-
tions, such as severe scrubbing around the whole body, puffi-
ness, and cyanosis around the eyes and mouth, followed by
labored respiration and decreased activity after prodding.
Mice sensitized with the low dose (1 mg/mouse+CT) and
medium dose (5 mg/mouse+CT) of whole crude buckwheat
extract exhibited more severe reactions than those sensitized
with the high dose (25 mg/mouse+CT). Fatal or near-fatal
anaphylaxis did not occurred in this study. Sham-sensitized
and naive mice did not show any symptoms of anaphylaxis
(Fig. 1). These results show that the initial sensitizing dose
may influence the intensity of hypersensitivity reactions. We
concluded that sensitization with buckwheat at the dose of
1 mg or 5 mg/mouse (low or medium dose) was optimal and
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Fig. 1. Buckwheat (BW)-induced systemic anaphylaxis symptom
score. Mice (n=6-8 in each group) were sensitized with crude ex-
tract of fresh buckwheat flour, 1 mg, 5 mg or 25 mg ig. per mouse
per dose, respectively mixed with cholera toxin (CT). Mice were
challenged ig with crude buckwheat extract (10 mg/mouse) in 2
doses at 30 min intervals at week 3. *p<0.05 vs. **Data are the com-
bined results of 2 separate experiments with the same protocol.
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Fig. 2. Levels of buckwheat (BW)-specific IgE (A) and chow-protein specific IgE (B) antibodies. Individual sera from different groups of
mice, (n=6-8 in each group) were obtained weekly following initial buckwheat-sensitization. IgE levels were determined by ELISA. Data
are given as mean±SEM of 6-8 individual sera. *: Statistically different among experimental groups, p<0.05 by t-tests.
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that one of these doses should be used for subsequent study.
Buckwheat-specific antibody responses following sensiti-
zation and challenge 
To explore the humoral immune responses underlying the
development of buckwheat-induced hypersensitivity, sera
from the different groups of mice were obtained weekly after
ig sensitization and challenge. Levels of buckwheat-specific
antibodies were determined by ELISA. Buckwheat-specific
IgE concentrations were significantly increased from experi-
mental week 1 through to week 4 in mice sensitized with
low and medium dose groups, whereas the initial increment
of buckwheat-specific IgE response was blunted after week
2 in the high dose group (Fig. 2A). Furthermore, buckwheat-
specific IgE levels were consisted with systemic anaphylaxis
symptom scores at week 3.
Buckwheat-specific IgG1 levels were also significantly dif-
ferent for the low/medium and  high dose groups at weeks 3
and 4 (Fig. 3A). Similar to buckwheat specific IgG1 respons-
es, IgG2a levels in the high dose group were significantly
lower than in the low and medium dose groups from week
2 through to week 4 (Fig. 3B).
IgE responses to chow-protein extract
To determine IgE responses to daily-fed mouse chow pro-
tein extract, IgE antibodies against crude protein extract of
mouse chow were measured by ELISA. Although, small chow-
specific IgE responses were detected in the sham-sensitized
group of mice after week 2, the levels of chow-specific IgE
antibodies were negligible in all groups of mice (Fig. 2B).
Splenocyte proliferative responses to crude buckwheat
extract
To characterize T-cell proliferative responses to crude buck-
wheat extract in this model, spleen cells from buckwheat aller-
gic mice, sham sensitized mice, and naive mice were cultured
with crude buckwheat extract (50 and 250 g/mL) at week 4
(Fig. 4). Although cells from all groups of mice, including CT
S
e
r
u
m
 
B
W
-
I
g
G
1
 
(
g
/
m
L
)
50
40
30
20
10
0
01234
Experimental weeks
BW 1 mg+CT
BW 5 mg+CT
BW 25 mg+CT
CT only
Naive
*
*
* *
*
Fig. 3. Levels of buckwheat (BW)-specific IgG1 (A) and IgG2a (B) antibodies. Individual sera from different groups of mice, (n=6-8 in each
group) were obtained weekly following initial buckwheat-sensitization. Antibody levels were determined by ELISA. Data are given as mean
±SEM of 6-8 individual sera. *: Statistically different among experimental groups, p<0.05 by ANOVA.
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Fig. 4. Splenocyte proliferative responses to crude buckwheat
(BW) extract stimulation. Spleen cells from buckwheat allergic mice
(n=2) and cholera toxin (CT) control mice (n=2) were stimulated
with 50 and 250  g/mL of buckwheat extracts, or with Con A. The
cells cultured in medium only served as a negative control. Three
days later, the cultures received an 18-hr pulse of 1  Ci per well
of 
3H-thymidine. The cells were harvested and the incorporated
radioactivity was counted. The results are expressed as cpm. The
proliferative potency are given as stimulation index (SI) over neg-
ative control. *, p<0.05 vs. **by t-test.
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control mice, showed significant proliferative responses to
Con A stimulation, cells from buckwheat-sensitized mice,
but not from sham-sensitized mice, exhibited significant pro-
liferative responses to crude buckwheat extract. Unlike buck-
wheat specific IgE and IgG responses, antigen stimulated pro-
liferative responses of splenocytes from the high dose group
of mice were as strong as those from low dose mice. 
Antigen specific T-cell cytokine responses
To determine the pattern of T-cell cytokine responses in
this model, splenocyte cultures were performed with buck-
wheat extracts and Con A stimulations. As shown in Fig. 5,
buckwheat specific IL-4 responses were significantly increased
in the low-, medium-, and high-dose groups of mice, where-
as antigen specific IL-5 responses were markedly increased
only in the low-dose group. Furthermore, Con A seemed to
have a slight stimulatory effects on IL-4 and IL-5 responses.
Similar to Th2-type cytokine responses, buckwheat-specific
IFN- responses were also predominant in buckwheat-sen-
sitized mice, and were highest in the low-dose group. More-
over, the productions of IFN- were higher in the presence
Fig. 5. Levels of IL-4 (A) and IL-5 (B). Spleen cells from buckwheat (BW) allergic mice (n=2) and cholera toxin (CT) control mice (n=2) were
stimulated with 250  g/mL of crude buckwheat extracts, or with Con A. The cells cultured in medium only served as a negative control. Levels
of cytokines were determined by in 3 day-culture supernatant by ELISA. Data are given as mean±SEM. *, p<0.05 vs. **, **, p<0.05 vs. ***.
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Fig. 6. Levels of IFN- . Spleen cells from buckwheat (BW) allergic
mice (n=2) and cholera toxin (CT) control mice (n=2) were stimu-
lated with 250  g/mL of crude buckwheat extracts, or with Con A.
The cells cultured in medium only served as a negative control.
Levels of cytokines were determined by in 3 day-culture super-
natant by ELISA. Data are given as mean±SEM. *, p<0.05 vs.
**, **, p<0.05 vs. ***.
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Fig. 7. Levels of IL-10. Spleen cells from buckwheat (BW) allergic
mice (n=2) and cholera toxin (CT) control mice (n=2) were stimu-
lated with 250  g/mL of crude buckwheat extracts, or with Con A.
The cells cultured in medium only served as a negative control.
Levels of cytokines were determined by in 3 day-culture super-
natant by ELISA. Data are given as mean±SEM. *, p<0.05 vs. **,
**, p<0.05 vs. ***.
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of Con A stimulation than in those with buckwheat stimu-
lation (Fig. 6). Buckwheat specific IL-10 productions were
also increased in buckwheat-sensitized mice, however in this
model, IL-10 productions were markedly more induced by
Con A stimulation than by antigen stimulation (Fig. 7).
DISCUSSION
Buckwheat sensitization occurs frequently by ingestion (1,
2, 10, 13, 14), and several related clinical reports have been
published on buckwheat allergy during the past 30 yr, espe-
cially in Asia and Europe. However, a lack of epidemiologi-
cal studies made it difficult to estimate prevalences or inci-
dences. In Korea, buckwheat flour is one of the important
food allergens in school children and adults, with a positive
skin test rate of about 5% (9), and because of its nutritional
advantages, buckwheat ingestion as a health food appears to
be on the increase. Several case reports are available on buck-
wheat hypersensitivity in Korea (10-12), Japan (8), and more
recently in Europe (15). As occurs in peanut allergy, allergic
reactions to buckwheat are frequently severe and sometimes
near fatal, furthermore some degree of cross allergenicity is
suspected with wheat or rice, as was found during our pre-
vious studies (25). However, immunological and clinical stud-
ies on buckwheat allergy are lacking. Consequently, effective
animal models of buckwheat allergy, which are capable of
mimicking the immunological characteristics of buckwheat
allergy in man, would be extremely valuable for mechanis-
tic research into grain allergies, such as, buckwheat, wheat
and rice allergies. As far as we know, this study is the first
report about an animal model of buckwheat allergy. In the
present study, we generated a murine model of buckwheat
allergy induced by intragastric sensitization and challenge.
Although in this study, the precise mechanisms involved in
the sensitization at gastrointestinal sites, and systemic ana-
phylaxis following ingestion of buckwheat were unknown,
observations of markedly increased  buckwheat specific serum
IgE and IgG1 antibodies, buckwheat stimulated splenocyte
proliferations, and IL-4 and IL-5 production were definitely
induced by the model. 
It has been demonstrated that IgE plays an important role
in mediating immediate type food allergy in humans (1, 26-
28) and in animal models (23, 28, 29). In the present study,
we found that buckwheat specific-IgE significantly increas-
es through week 1 to 4-week following initial sensitization,
especially in the low (1 mg/dose) and medium (5 mg/dose)
dose sensitized groups of mice. Furthermore, buckwheat spe-
cific IgE levels at week 3 were consistent with symptom scores
by intragastric buckwheat challenge at week 3. However, in
this study, we could not confirm that the systemic anaphy-
lactic symptoms stemmed from increased IgE levels, because
we did not perform PCA reactions with positive sera. On the
other hand, to determine IgE responses to daily-fed mouse
chow protein extract, we measured IgE antibodies against
crude protein extract of mouse chow by ELISA. We found
that the levels of chow-specific IgE antibodies were negligi-
ble in all groups of mice through the experimental, which is
a unique result that has not been discussed in other animal
models of food allergy (23, 28). In the present study, to eval-
uate the differential effect of antigen doses during intragastric
sensitization, we sensitized mice using three different doses
of buckwheat extract. Interestingly, in the high dose (25 mg/
dose) sensitized group of mice, the initial increment of buck-
wheat-specific IgE response was blunted after week 2, and
buckwheat-specific IgE responses were significantly lower
than this at week 3. Consistent with buckwheat-specific IgE
levels, anaphylaxis symptom scores were lowest at week 3
among the three groups of buckwheat sensitized mice. Buck-
wheat-specific IgG1 responses showed patterns similar to
those of IgE responses. Further studies are needed to evaluate
the precise roles of both kinds of antibodies in this model.
To further assess the suitability of this model, we assessed T
cell responses to buckwheat extract using a splenocyte culture
system. We found significant proliferative responses to buck-
wheat extract stimulation in buckwheat-sensitized mice. Even
though the degrees of splenocyte proliferations (presented by
stimulation index) were highest in the cultures with Con A
stimulation, relatively high (stimulation index: 7-10) levels of
proliferations were observed in buckwheat stimulated cultures.
Moreover, unlike buckwheat specific-IgE and -IgG responses,
buckwheat stimulated proliferative responses in the high dose
group of mice were as strong as those in the low dose group. 
In addition, we confirm that buckwheat specific IL-4 res-
ponses were significantly increased in the low-, medium-, and
high-dose groups of mice, and were highest in the low-dose
group. However, antigen specific IL-5 responses were marked-
ly increased only in the low-dose group. Furthermore, Con
A seemed to have a relatively low stimulatory effects on Th2-
type cytokines in this study. Similar to Th2-type cytokine
responses, buckwheat-specific IFN- responses also predomi-
nated in buckwheat-sensitized mice, were highest in the low-
dose group, and productions of IFN- were higher for Con
A stimulation than for buckwheat stimulation. Buckwheat
specific IL-10 productions were also increased in buckwheat-
sensitized mice, but we could unearth either positive, or nega-
tive relations between IL-10 and levels of buckwheat specific
IgE, or buckwheat stimulated IL-4 production. One impor-
tant discussion point concerns the several possible effects of
endotoxin contained in fresh crude buckwheat extract. Since
studies have been performend on the fungal contamination
derived endotoxin in storage grains, such as rice, wheat and
buckwheat, and the direct effect of endotoxin on cytokine
production by mouse T-cells (30, 31), we measured endotoxin
levels in the  crude buckwheat flour extract used in the pre-
sent study. Its level was 616 EU/mg in our buckwheat extract,
and thus we performed this experiment without eliminat-
ing endotoxin. Thus we could consider the possible effects of572 S.-Y. Lee, S. Oh, K. Lee, et al.
endotoxin on the production of all kinds of cytokines (i.e.,
IL-4, IL-5, IL-12, IL-10, IFN- ) and on the proliferation of
splenocytes in culture (31). However, fortunately, according
to our experimental data, upon splenocyte proliferation and
cytokine production, we found no additive influence of endo-
toxin on the proliferation capacities and cytokine productivi-
ties in naive or sham control mice. Thus we could use this
model as a good quality of buckwheat allergy model in future
study. And we need to repeat this experiment with endotox-
in free or heated buckwheat extract in the future.
In conclusion, we established a mouse model of buckwheat
allergy using intragastric sensitization and challenge, which
closely reflects the clinical and immunological characteristics
of immediate type food allergy in man. Buckwheat-induced
allergic reactions in this model are IgE or IgG1-mediated,
and buckwheat stimulated T-cell response up-regulation was
observed. Using this model, we will extend our research on
buckwheat allergy, for example, to identify and evaluate the
major allergenic components of buckwheat extract, to confirm
cross allergenicities with other crops, to test the capability
of IgE induction without adjuvant during sensitization, and
to develop therapeutic modalities for buckwheat allergy.
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